ArticleCancer management and research2022

Clinical Outcomes of Patients with Peritoneal Metastasis-Only Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI Through Irinotecan Dose Escalation According to

Ching-Chun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.